Edit Reading

Back to List

Basic Information

Title

Please enter a title.

URL

Please enter a valid URL.

Date

カテゴリID

画像ファイル名

単語数（空欄の場合は本文から自動計算）空欄の場合は本文から自動計算されます。本文が空欄の場合は既存の値が保持されます。

統計情報

現在の単語数: 169語

読了回数: 0回

作成日: 2023/08/01 12:11

更新日: 2025/12/09 01:25

本文

An expert panel at Japan&#039;s health ministry has approved the use of a coronavirus vaccine developed by major Japanese pharmaceutical firm Daiichi Sankyo.
                
It will be the first formally authorized COVID-19 vaccine developed by a domestic company after the completion of procedures by the ministry.
                
The panel approved the vaccine on Monday, saying the experts confirmed its effectiveness and safety.
                
Japan has been using vaccines developed by foreign firms such as Pfizer and Moderna, as there have been no domestically-developed ones.
                
In January, Daiichi Sankyo filed an application with the ministry for approval of its messenger RNA vaccine, the same type as ones developed by both Pfizer and Moderna.
                
The vaccine targets the original strain of the virus. It is designed to enhance immunity by creating part of a spike protein in the human body through the administration of artificially produced mRNA.
                
At Monday&#039;s meeting, the panel also discussed a coronavirus vaccine developed by another Japanese pharmaceutical company Shionogi, but the experts decided to continue their deliberation on it.

メモ

メモ・感想

キャンセル

Edit Reading

Basic Information

統計情報

本文

メモ

Send Report